missing translation for 'onlineSavingsMsg'
Learn More
Learn More
p130 Monoclonal Antibody (130P215 (DCS-215)), Invitrogen™
Mouse Monoclonal Antibody
Brand: Invitrogen MA514305
This item is not returnable.
View return policy
Description
MA5-14305 targets p130/Rb2 in IF, IHC (P), IP, and WB applications and shows reactivity with Human and Rat samples. The MA5-14305 immunogen is a synthetic peptide from p130 corresponding to aa878-913.
RBL2 (also known as p130) or Retinoblastoma-like protein 2 is a key regulator of entry into cell division. It is directly involved in heterochromatin formation by maintaining overall chromatin structure and (in particular) that of constitutive heterochromatin by stabilizing histone methylation. RBL2 recruits and targets histone methyltransferases KMT5B and KMT5C leading to epigenetic transcriptional repression. It controls histone H4 'Lys20' trimethylation. It probably also acts as a transcription repressor by recruiting chromatin-modifying enzymes to promoters. RBL2 serves as a potent inhibitor of E2F-mediated trans-activation and associates preferentially with E2F5.
Specifications
p130 | |
Monoclonal | |
0.4 mg/mL | |
PBS with 0.2% BSA and 0.09% sodium azide; pH 7.4 | |
Q08999 | |
RBL2 | |
A synthetic peptide from p130 corresponding to aa878-913 | |
500 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot | |
130P215 (DCS-215) | |
Unconjugated | |
RBL2 | |
130 kDa retinoblastoma-associated protein; FLJ26459; p130; PPAR-alpha-interacting complex protein 128; PRB2; PRIC128; RB transcriptional corepressor like 2; Rb2; rb2 p130; Rbl2; RBR-2; retinoblastoma-like 2; retinoblastoma-like 2 (p130); retinoblastoma-like protein 2; Retinoblastoma-related protein 2 | |
Mouse | |
Protein G | |
RUO | |
5934 | |
4° C | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
p130 Monoclonal Antibody (130P215 (DCS-215)), Invitrogen™ > 500 μL; Unconjugated
Spot an opportunity for improvement?Share a Content Correction